The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions Suzanne B. CoopeyEmanuele MazzolaKevin S. Hughes Review 02 November 2012 Pages: 627 - 633
Use of antidepressants and the risk of breast cancer: a meta-analysis Chun-Sick EomSang Min ParkKyung-Hwan Cho Review 09 November 2012 Pages: 635 - 645
Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer Ana RochaLei WangManuela Martins-Green Preclinical Study 12 October 2012 Pages: 647 - 658
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients María P. RobertiYamila S. RoccaEstrella M. Levy Preclinical Study 14 October 2012 Pages: 659 - 671
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models Yesim Gökmen-PolarYi LiuGeorge W. Sledge Jr. Preclinical Study 21 October 2012 Pages: 673 - 682
PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells Anna-Maria JeggToby M. WardMark D. Pegram Preclinical Study 23 October 2012 Pages: 683 - 692
Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells? Anguraj SadanandamAseem LalChristopher C. Benz Preclinical Study Open access 27 October 2012 Pages: 693 - 703
Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer Anoek H. J. Verschuur-MaesPeter C. de BruinPaul J. van Diest Preclinical study 27 October 2012 Pages: 705 - 715
Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours Brigid C. BrowneAlex J. EustaceNorma O’Donovan Preclinical study 02 November 2012 Pages: 717 - 727
Alcohol consumption suppresses mammary tumor metastasis in a syngeneic tumor transplantation model Beth A. VorderstrasseTao WangGary G. Meadows Preclinical Study 02 November 2012 Pages: 729 - 737
Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells Chi ZhangXuening DuanYinhua Liu Preclinical Study 02 November 2012 Pages: 739 - 748
Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls Angela R. BradburyLinda Patrick-MillerMary B. Daly Clinical Trial 14 October 2012 Pages: 749 - 757
Phase II open-label study of sunitinib in patients with advanced breast cancer Denise A. YardleyE. Claire DeesDennis L. Citrin Clinical Trial 17 October 2012 Pages: 759 - 767
Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study Kishor M. WasanPaul E. GossJames N. Ingle Clinical Trial 23 October 2012 Pages: 769 - 776
Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer Joanne L. BlumCarlos H. BarriosJulie Gralow Clinical trial 27 October 2012 Pages: 777 - 788
Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer C. F. JehnB. FlathD. Lüftner Clinical trial 03 November 2012 Pages: 789 - 794
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up L. MalorniP. B. ShettyG. Arpino Clinical trial 04 November 2012 Pages: 795 - 804
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses’ Health Studies Megan S. RiceShelley S. TworogerRulla M. Tamimi Epidemiology 21 October 2012 Pages: 805 - 812
Time to diagnosis and breast cancer stage by race/ethnicity Erica T. WarnerRulla M. TamimiAnn H. Partridge Epidemiology 26 October 2012 Pages: 813 - 821
Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality Yaojen ChangClyde B. SchechterJeanne S. Mandelblatt Epidemiology Open access 27 October 2012 Pages: 823 - 835
Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case–control study in the Multiethnic Cohort study Yeonju KimNicholas J. OllberdingMarc T. Goodman Epidemiology 31 October 2012 Pages: 837 - 845
The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case–control study and a meta-analysis Wei ChenRong ZhongTao Huang Epidemiology 02 November 2012 Pages: 847 - 857
Pattern of follow-up care and early relapse detection in breast cancer patients Sandra M. E. GeurtsFemmie de VegtVivianne C. G. Tjan-Heijnen Epidemiology 02 November 2012 Pages: 859 - 868
Germline mutations in RAD51C in Jewish high cancer risk families Anya KushnirYael LaitmanEitan Friedman Epidemiology 02 November 2012 Pages: 869 - 874
Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer Lingeng LuGuangjian ZhuHerbert Yu Epidemiology 03 November 2012 Pages: 875 - 883
Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis Liping ZhouFan YaoQihui Wang Epidemiology 04 November 2012 Pages: 885 - 897
Patients’ willingness to participate in a breast cancer biobank at screening mammogram Christoph I. LeeLawrence W. BassettArash Naeim Epidemiology 06 November 2012 Pages: 899 - 906
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer Mohammad R. AkbariWojciech KluźniakCezary Cybulski Brief Report Open access 26 October 2012 Pages: 907 - 909
The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome Cheryl M. LewisDawei BuDavid M. Euhus Brief Report 07 November 2012 Pages: 911 - 918
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference Masakazu ToiJohn R. BensonTakashi Inamoto Brief Report 11 November 2012 Pages: 919 - 926
Comment on prognostic and therapeutic implications of mTORC2 and rictor expression in human breast cancer U. WazirR. F. NewboldK. Mokbel Letter to the Editor 29 September 2012 Pages: 927 - 929
Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients Ava KwongEnders K. O. NgEdmond S. K. Ma Letter to the Editor Open access 26 October 2012 Pages: 931 - 933
Erratum to: Women’s features and inter-/intra-rater agreement on mammographic density assessment in full-field digital mammograms (DDM-SPAIN) Beatriz Pérez-GómezFranciso RuizDolores Salas Erratum 07 November 2012 Pages: 935 - 935
Erratum to: Effect of a mixed solution of sodium hyaluronate and carboxymethyl cellulose on upper limb dysfunction after total mastectomy: a double-blind, randomized clinical trial Eun Joo YangEunyoung KangSung-Won Kim Erratum 09 November 2012 Pages: 937 - 937
